Successful treatment of rhinocerebral zygomycosis: A combined-strategy approach

Clinical Infectious Diseases

Volumn 28, Issue 1, 1999, Pages 160-161

  Milton Gaviria, J ^b   Grohskopf, Lisa A ^b   Barnes, Robert ^b   Root, Richard K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX;

ADULT; ANAMNESIS; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; ENUCLEATION; HUMAN; MALE; MAXILLA RESECTION; MUCORMYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0032989262     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517193     Document Type: Article

References (4)

1. Sugar AM. Mucormycosis. Clin Infect Dis 1992;14(suppl 1):S126-9.
2. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1-9.
3. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony stimulating factor. Clin Infect Dis 1997;24:192-6.
4. Sahin B, Paydas S, Cosar E, Bicakci K, et al. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. Eur J Clin Microbiol Infect Dis 1996;15:866-9.